Literature DB >> 8606280

Aortic regurgitation complicated by extreme left ventricular dilation: long-term outcome after surgical correction.

E Klodas1, M Enriquez-Sarano, A J Tajik, C J Mullany, K R Bailey, J B Seward.   

Abstract

OBJECTIVES: This study sought to determine the outcome of aortic valve replacement for aortic regurgitation complicated by extreme left ventricular dilation.
BACKGROUND: Aortic valve replacement has been recommended in aortic regurgitation with extreme left ventricular dilation (diastolic dimension >/= 80 mm), but extreme left ventricular dilation raises concern about irreversible left ventricular dysfunction.
METHODS: Thirty-one patients with a preoperative echocardiographic diastolic dimension >/= 80 mm (group 1) undergoing operation for severe isolated aortic regurgitation between 1980 and 1989 were compared with 188 patients with a diastolic dimension <80 mm operated on during the same period (group 2).
RESULTS: Preoperatively, extreme left ventricular dilation was seen only in male patients and was associated with a reduced ejection fraction (43 +/- 12% vs. 53 +/- 11% [mean +/- SD], p < 0.0001). The postoperative outcome of group 1 was compared with that of male patients in group 2 (group 2M, n = 144). The operative mortality rates for groups 1 and 2M were 0% and 5.6%, respectively (p = 0.35). Late survival in operative survivors was similar in groups 1 and 2M, but compared with expected survival, an excess mortality was observed for group 1 (p = 0.024). Preoperative ejection fraction, but not diastolic dimension, independently predicted late survival and postoperative ejection fraction. Postoperatively, groups 1 and 2M showed a similar improvement in ejection fraction, but persistent left ventricular enlargement was more frequent in group 1.
CONCLUSIONS: Extreme left ventricular dilation due to aortic regurgitation is observed in male patients and is frequently associated preoperatively with a reduced ejection fraction but is not a marker of irreversible left ventricular dysfunction. Operative risk and late postoperative survival are acceptable in these patients, although a late excess mortality, predicted best by preoperative ejection fraction, is observed. Therefore, extreme left ventricular dilation is not a contraindication to operation, which should be performed before left ventricular dysfunction occurs.

Entities:  

Mesh:

Year:  1996        PMID: 8606280     DOI: 10.1016/0735-1097(95)00525-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Evaluation of postoperative cardiac function and long-term results in patients after aortic valve replacement for aortic valve disease with increased left ventricular mass.

Authors:  M Natsuaki; T Itoh; Y Okazaki; H Ishida; M Hamada; K Rikitake; K Naitoh
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-01

Review 2.  Timing of aortic valve surgery.

Authors:  C M Otto
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

3.  Aortic Regurgitation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

Review 4.  Aortic regurgitation.

Authors:  Gerald Maurer
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

5.  Predictors of left ventricular performance after valve replacement in children and adolescents with chronic aortic regurgitation.

Authors:  R I Tafreshi; A Shahmohammadi; P N Davari
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 6.  Contemporary reviews by surgeon: timing of operation for chronic aortic regurgitation.

Authors:  Kazuhiro Taniguchi; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-26

Review 7.  Asymptomatic valvular disease: who benefits from surgery?

Authors:  Naomi F Botkin; Paula S Seth; Gerard P Aurigemma
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

8.  Long term results and predictors of left ventricular function recovery after aortic valve replacement for chronic aortic regurgitation.

Authors:  Hiroyuki Saisho; Koichi Arinaga; Satoshi Kikusaki; Yuichiro Hirata; Kumiko Wada; Tatsuyuki Kakuma; Hiroyuki Tanaka
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

9.  Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

Authors:  Jeffrey S Borer; Phyllis G Supino; Edmund McM Herrold; Antony Innasimuthu; Clare Hochreiter; Karl Krieger; Leonard N Girardi; O Wayne Isom
Journal:  Cardiology       Date:  2018-08-23       Impact factor: 1.869

Review 10.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.